Skip to content

Ambulatory versus Conventional Inpatient Surgery in Low-Risk Hepatectomy: A Non-inferiority Randomized Controlled Trial

Ambulatory versus Conventional Inpatient Surgery in Low-Risk Hepatectomy: A Non-inferiority Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600128913
Enrollment
Unknown
Registered
2026-07-28
Start date
2026-08-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver tumor

Interventions

Day surgery group:Offer the patient a day surgery.
The conventional surgery group:Provide the patient with routine inpatient surgical treatment.

Sponsors

The First Medical Center of the General Hospital of the People's Liberation Army of China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-75 years, both genders. 2. ECOG performance status 0-1. 3. American Society of Anesthesiologists (ASA) physical status grade I-II. 4. Planned to undergo one of the following three types of surgery: (1) Left lateral hepatic lobectomy; (2) Anatomical segmentectomy (<=2 liver segments); (3) Non-anatomical wedge hepatectomy. 5. Physiological condition suitable for robot-assisted laparoscopic surgery. 6. Willing to cooperate and complete the study follow-up and related examinations.

Exclusion criteria

Exclusion criteria: Subjects meeting any of the following criteria will be excluded from enrolment in this study: 1. The patient or their legally authorized representative refuses to sign the informed consent form and refuses to participate in this study. 2. Presence of severe comorbidities involving the heart, lungs, kidneys, or other vital organs, or contraindications to anesthesia or surgery. 3. Preoperative imaging suggests tumor invasion of adjacent organs or distant metastasis. 4. History of previous liver surgery on the same side. 5. Presence of uncorrectable coagulation dysfunction (INR >1.5 or platelet count <50×10/L). 6. Pregnant or breastfeeding women. 7. Severe psychiatric disorders or cognitive impairment that prevent cooperation with study procedures and follow-up. 8. Living alone or without a fixed caregiver (as adult companionship is required after discharge from day surgery). 9. Residence located more than 1 hour's drive from the hospital (to ensure the ability to return to the hospital promptly in case of emergency). 10. Participation in other clinical trials within 3 months before enrollment that may affect the outcome measures of this study.

Design outcomes

Primary

MeasureTime frame
The rate of no complications occurring within 30 days after the surgery;Death rate;Readmission rate;

Secondary

MeasureTime frame
The operation time;Intraoperative blood loss;Pringle technique usage time;Intraoperative blood transfusion rate and volume;Operation conversion rate;The first meal intake time;First bed activity time;Abdominal drainage tube removal time;The R0 resection rate;Surgical margin distance ;Quality of Recovery-15;Patient satisfaction;Health economics indicators;

Countries

China

Contacts

Public ContactLiu Rong

The First Medical Center of the General Hospital of the People's Liberation Army of China

liurong301@126.com+86 10 6693 7591

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026